Table 3.
Characteristics | No urinary symptoms (N = 12) | Urinary symptoms (N = 23) | p-value |
---|---|---|---|
Age | |||
<50 | 8 (66.7) | 7 (30.4) | 0.07a |
≥50 | 4 (33.3) | 16 (69.6) | |
Gender, N (%) | |||
Male | 8 (66.7) | 9 (39.1) | 0.16a |
Female | 4 (33.3) | 14 (60.9) | |
Duration of disease in months, median (IQR) | 37.5 (97.5) | 87 (111) | 0.38b |
Use of ERT, N (%) | 11 (91.7) | 16 (69.6) | 0.22a |
Duration of ERT in months, median (IQR) | 33 (31) | 59 (42) | 0.04b |
Use of ambulatory assistance, N (%) | 3 (25) | 15 (65.2) | 0.07a |
LE functional scores ≥3 | 0 (0) | 11 (47.8) | 0.005a |
6 MWT in meters, median (IQR) | 415.8 (124.4) | 335 (188.5) | 0.003b |
Use of BIPAP, N (%) | 5 (41.7) | 11 (47.8) | 1a |
aFisher’s exact test, two tailed
bMann–Whitney test, two tailed